ArticlePloS one2025
RETRACTED: Application of IRSA-BP neural network in diagnosing diabetes.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
- Retraction · 2026-07-22Concerns/Issues about Article · Concerns/Issues about Results and/or Conclusions ·
- Retracted
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Within the healthcare sector, the application of machine learning is gaining prominence, notably enhancing the efficiency and precision of diagnostic procedures. This study focuses on this key area of diabetes prediction and aims to develop an innovative prediction method. Using the data set published by Kare, this paper constructs and compares various intelligent systems based on multilayer algorithms, and specifically introduces improved reptile search algorithm (IRSA) to optimize the weight and threshold initialization of traditional backpropagation (BP) neural networks. This improvement aims to improve the network performance and accuracy in diabetes detection. In the study, the IRSA-BP hybrid algorithm and many other machine learning algorithms were used for diabetes prediction, and the algorithm performance was comprehensively evaluated using multiple classification metrics. The experimental results showed that the IRSA-BP algorithm performed the best among all the evaluated algorithms, with an accuracy of up to 83.6%, showing its superior performance in diabetes prediction. Therefore, the IRSA-BP classifier has an important potential for application in the medical field. It can assist medical professionals to identify diabetes risk earlier and assess the condition more accurately, thus improving diagnostic efficiency and accuracy. This is important for early intervention and treatment of patients with diabetes and to improve their health status and quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.